Robert Lindsay
Family Medicine · Orrville, OHNPI 1144383043
Payments from drug & device makers
Across 237 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$772
- AbbVie$508
- Novo Nordisk$431
- Lilly USA, LLC$287
- Boehringer Ingelheim$222
- Sanofi-aventis U.S. LLC$152
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,61697%
- Education$1053%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $772 |
| AbbVie(2 entities) | 34 | $508 |
| Novo Nordisk | 37 | $431 |
| Lilly USA, LLC | 20 | $287 |
| Boehringer Ingelheim | 16 | $222 |
| Sanofi-aventis U.S. LLC | 10 | $152 |
| Merck | 13 | $137 |
| Astellas Pharma US Inc | 3 | $124 |
| Pfizer | 7 | $116 |
| Abbott | 6 | $103 |
| Bayer | 7 | $92 |
| Amarin Pharma, Inc. | 2 | $78 |
| Johnson & Johnson | 6 | $77 |
| Xeris Pharmaceuticals, Inc. | 4 | $69 |
| E.r. Squibb & Sons, L.L.C. | 5 | $59 |
| Amgen | 4 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $52 |
| Novartis | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Genentech USA, Inc. | 2 | $42 |
| Exact Sciences | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Dexcom, Inc. | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| GSK | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Bioventus LLC | 1 | $12 |
| Bsn Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$230
- SYMBICORT$115
- BYDUREON$115
- BEVESPI AEROSPHERE$115
- BREZTRI$115
How this compares
$3,721 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 135 | $143,213 |
| EliquisApixaban | 140 | $119,667 |
| FarxigaDapagliflozin Propanediol | 82 | $91,683 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $60,888 |
| OzempicSemaglutide | 47 | $60,611 |
| JardianceEmpagliflozin | 47 | $53,755 |
| XareltoRivaroxaban | 46 | $43,376 |
| MounjaroTirzepatide | 37 | $42,419 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $34,724 |
| MyrbetriqMirabegron | 64 | $26,004 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 13 | $24,007 |
| Nurtec OdtRimegepant Sulfate | 15 | $23,659 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $13,253 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 14 | $13,069 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 58 | $11,667 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $287 | $185,631172 claims |
| PfizerEliquis, Nurtec Odt | $116 | $143,326155 claims |
| AstraZenecaFarxiga, Bevespi Aerosphere | $772 | $97,41293 claims |
| Novo NordiskOzempic | $431 | $60,61147 claims |
| Boehringer IngelheimJardiance | $222 | $53,75547 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $16 | $47,97758 claims |
| Johnson & JohnsonXarelto | $77 | $43,37646 claims |
| Astellas Pharma US IncMyrbetriq | $124 | $26,00464 claims |
| MerckJanumet Xr | $137 | $13,06914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Orrville
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.